Abstract

The growing interest in 3-methylcytidine (m3C) originates from the recent discoveries of m3C modified tRNAs in humans as well as its intensively debated occurrence in mRNA. Moreover, m3C formation can be catalyzed by RNA without the assistance of proteins as has been demonstrated for a naturally occurring riboswitch fold using the methylated form of its cognate ligand as cofactor. Additionally, new RNA sequencing methods have been developed to detect this modification in transcriptome-wide manner. For all these reasons, an increasing demand for synthetic m3C containing oligoribonucleotides is emerging. Their chemical synthesis relies on RNA solid-phase synthesis using phosphoramidite building blocks. Here, we describe a facile synthetic path towards N4-acetylated 2′-O-TBDMS- and 2′-O-TOM m3C phosphoramidites to provide an optimal toolbox for solid-phase synthesis of m3C containing RNA.Graphical abstract

Highlights

  • More than 170 different nucleoside modifications have been identified in non-coding and coding RNAs [1,2,3,4]

  • Our synthesis started from commercially available cytidine which was selectively methylated at position N3 by iodomethane to yield the corresponding hydroiodide salt of ­m3C 1 (Scheme 1) [21]

  • Introduction of the 2′-O-TBDMS group was accomplished by treatment with tert-butyldimethylsilyl chloride under basic conditions [24,25,26] resulting in a mixture of 2′ and 3′ regioisomers that was separated by column chromatography, 1 3

Read more

Summary

Introduction

More than 170 different nucleoside modifications have been identified in non-coding and coding RNAs [1,2,3,4].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call